Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications

Virus Research

Volumn 21, Issue 2, 1991, Pages 111-122

  Muzychenko, Arkady R ^a   Lipskaya, Galina Yu ^b   Maslova, Svetlana V ^a   Svitkin, Yuri V ^a   Pilipenko, Evgeny V ^a   Nottay, Baldev K ^c   Kew, Olen M ^c   Agol, Vadim I ^a,b  

^a CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

5' Untranslated region; Mutation; Poliovirus; Translation; Vaccine strain

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; MUTATION RATE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RNA TRANSLATION; VACCINATION; VIRUS STRAIN;

BASE SEQUENCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, VIRAL; HUMAN; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NUCLEOTIDES; POLIOVIRUS VACCINE, ORAL; POLIOVIRUSES; RNA, VIRAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSLATION, GENETIC;

HUMAN POLIOVIRUS 1; POLIOVIRUS; RHINOVIRUS;

EID: 0025953086     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(91)90002-D     Document Type: Article

References (41)

1. Genetic determinants of neurovirulence and attenuation of poliovirus
2. The 5'-untranslated region of picornaviral genomes
3. An internal 5'-noncoding region required for translation of poliovirus RNA in vitro
4. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine
5. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature
6. Unusual requirements for optimum translation of polio viral RNA in vitro
7. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
8. Antigenic and biochemical characterization of poliovirus type 2 isolated from two cases of paralytic disease
9. The susceptibility of infants to infection with natural (‘wild’) and attenuated (vaccine) strains of poliovirus
10. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype
11. Evolution of the oral poliovaccine in human occurs by both mutation and intramolecular recombination
12. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans
13. Genotypic relationship among wild polioviruses from different regions of the world
14. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: Function of the 5' noncoding sequence in viral replication
15. Intertypic recombinations between vaccine virus strains isolated from polio cases
16. The nature of strains isolated from polio cases in Byelorussia in 1967–1985
17. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases
18. Comparative biochemical studies of type 3 poliovirus
19. Characterization of strains of type 3 poliovirus by oligonucleotide mapping
20. The effect of sequences in the 5' non-coding region on the replication of polioviruses in the human gut
21. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee
22. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain
23. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans
24. Genetic analysis of the attenuation phenotype of poliovirus type 1
25. Field safety and efficacy of live attenuated poliovirus vaccines
26. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells
27. Internai initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA
28. Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts
29. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region
30. Distinct modes of poliovirus polyprotein initiation in vitro
31. Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence
32. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine
33. Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses
34. History of Sabin attenuated poliovirus oral live vaccine strains
35. New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence
36. 472→U
37. The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies
38. Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains
39. An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis
40. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
41. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients